MRVI
MRVI
US56600D1072
Maravai LifeSciences Holdings,
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 185.743.000 259.185.000
28.3%
Cost of Revenue 151.753.000 150.876.000
0.6%
Gross Profit 33.990.000 108.309.000
68.6%
162.520.000 180.992.000
10.2%
Operating Income -128.530.000 -72.683.000
76.8%
Pretax Income -234.974.000 -261.482.000
10.1%
Net Income Common Stockholders -130.773.000 -144.846.000
9.7%
-- --
--
-- --
--
ende